Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1979 4
1980 10
1981 16
1982 25
1983 34
1984 22
1985 37
1986 49
1987 67
1988 51
1989 55
1990 78
1991 88
1992 132
1993 156
1994 168
1995 203
1996 208
1997 230
1998 252
1999 341
2000 359
2001 445
2002 557
2003 625
2004 881
2005 1171
2006 1355
2007 1577
2008 1855
2009 2195
2010 2474
2011 2894
2012 3458
2013 4070
2014 4739
2015 5313
2016 5761
2017 6427
2018 7475
2019 8581
2020 10065
2021 11788
2022 13954
2023 13813
2024 12070
2025 31

Text availability

Article attribute

Article type

Publication date

Search Results

113,220 results

Results by year

Filters applied: . Clear all
Page 1
Clinical Features of Thalamic Stroke.
Chen XY, Wang Q, Wang X, Wong KS. Chen XY, et al. Curr Treat Options Neurol. 2017 Feb;19(2):5. doi: 10.1007/s11940-017-0441-x. Curr Treat Options Neurol. 2017. PMID: 28251587 Review.
Progressive Cellular Senescence Mediates Renal Dysfunction in Ischemic Nephropathy.
Kim SR, Puranik AS, Jiang K, Chen X, Zhu XY, Taylor I, Khodadadi-Jamayran A, Lerman A, Hickson LJ, Childs BG, Textor SC, Tchkonia T, Niewold TB, Kirkland JL, Lerman LO. Kim SR, et al. Among authors: chen x. J Am Soc Nephrol. 2021 Aug;32(8):1987-2004. doi: 10.1681/ASN.2020091373. Epub 2021 Jun 16. J Am Soc Nephrol. 2021. PMID: 34135081 Free PMC article.
Donafenib Versus Sorafenib in First-Line Treatment of Unresectable or Metastatic Hepatocellular Carcinoma: A Randomized, Open-Label, Parallel-Controlled Phase II-III Trial.
Qin S, Bi F, Gu S, Bai Y, Chen Z, Wang Z, Ying J, Lu Y, Meng Z, Pan H, Yang P, Zhang H, Chen X, Xu A, Cui C, Zhu B, Wu J, Xin X, Wang J, Shan J, Chen J, Zheng Z, Xu L, Wen X, You Z, Ren Z, Liu X, Qiu M, Wu L, Chen F. Qin S, et al. Among authors: chen x. J Clin Oncol. 2021 Sep 20;39(27):3002-3011. doi: 10.1200/JCO.21.00163. Epub 2021 Jun 29. J Clin Oncol. 2021. PMID: 34185551 Free PMC article. Clinical Trial.
Succinate dehydrogenase/complex II is critical for metabolic and epigenetic regulation of T cell proliferation and inflammation.
Chen X, Sunkel B, Wang M, Kang S, Wang T, Gnanaprakasam JNR, Liu L, Cassel TA, Scott DA, Muñoz-Cabello AM, Lopez-Barneo J, Yang J, Lane AN, Xin G, Stanton BZ, Fan TW, Wang R. Chen X, et al. Sci Immunol. 2022 Apr 29;7(70):eabm8161. doi: 10.1126/sciimmunol.abm8161. Epub 2022 Apr 29. Sci Immunol. 2022. PMID: 35486677 Free PMC article.
Editorial: Deciphering the Microbiome-Immunity-Cancer Axis.
Chen X, Jin C, Facciabene A, Guo X, Zhang Y. Chen X, et al. Front Immunol. 2022 Apr 14;13:897811. doi: 10.3389/fimmu.2022.897811. eCollection 2022. Front Immunol. 2022. PMID: 35493451 Free PMC article. No abstract available.
Biomedical polymers: synthesis, properties, and applications.
Chen WH, Chen QW, Chen Q, Cui C, Duan S, Kang Y, Liu Y, Liu Y, Muhammad W, Shao S, Tang C, Wang J, Wang L, Xiong MH, Yin L, Zhang K, Zhang Z, Zhen X, Feng J, Gao C, Gu Z, He C, Ji J, Jiang X, Liu W, Liu Z, Peng H, Shen Y, Shi L, Sun X, Wang H, Wang J, Xiao H, Xu FJ, Zhong Z, Zhang XZ, Chen X. Chen WH, et al. Among authors: chen x. Sci China Chem. 2022;65(6):1010-1075. doi: 10.1007/s11426-022-1243-5. Epub 2022 Apr 24. Sci China Chem. 2022. PMID: 35505924 Free PMC article. Review.
Efficient Nanovaccine Delivery in Cancer Immunotherapy.
Zhu G, Zhang F, Ni Q, Niu G, Chen X. Zhu G, et al. Among authors: chen x. ACS Nano. 2017 Mar 28;11(3):2387-2392. doi: 10.1021/acsnano.7b00978. Epub 2017 Mar 9. ACS Nano. 2017. PMID: 28277646 Review.
Synthetic nanomaterials for spleen-specific mRNA delivery.
Nie S, Yang B, Ma R, Zha L, Qin Y, Ou L, Chen X, Li L. Nie S, et al. Among authors: chen x. Biomaterials. 2024 Sep 28;314:122859. doi: 10.1016/j.biomaterials.2024.122859. Online ahead of print. Biomaterials. 2024. PMID: 39362024 Review.
FDA decisions on new oncological drugs.
Li G, Liu Y, He R, Su L, Chen X. Li G, et al. Among authors: chen x. Lancet Oncol. 2022 May;23(5):583-585. doi: 10.1016/S1470-2045(22)00136-X. Lancet Oncol. 2022. PMID: 35489340 No abstract available.
113,220 results
You have reached the last available page of results. Please see the User Guide for more information.